Anne E. White Eli Lilly & CO (LLY) insider trading activity

Anne E. White is EVP & Pres, Lilly Neuroscience of ELI LILLY & Co. Currently has a direct ownership of 74,209 shares of LLY, which is worth approximately $67.9 Million. The most recent transaction as insider was on Feb 10, 2025, when has been sold 6,828 shares (Common Stock) at a price of $868.88 per share, resulting in proceeds of $5,932,712. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 74.2K

13.18% 3M change

13.18% 12M change

Total Value Held $67.9 Million

Anne E. White Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 10 2025	BUY Grant, award, or other acquisition	$5,932,712 $868.88 p/Share	6,828 Added 8.43%	74,209 Common Stock
Feb 01 2025	SELL Payment of exercise price or tax liability	$1,181,743 $811.08 p/Share	1,457 Reduced 2.12%	67,380 Common Stock
Feb 01 2025	BUY Exercise of conversion of derivative security	-	3,269 Added 4.53%	68,838 Common Stock
Feb 12 2024	BUY Grant, award, or other acquisition	$3,953,925 $737.26 p/Share	5,363 Added 7.56%	65,569 Common Stock
Feb 01 2024	SELL Payment of exercise price or tax liability	$1,190,504 $645.61 p/Share	1,844 Reduced 2.97%	60,206 Common Stock
Feb 01 2024	BUY Exercise of conversion of derivative security	-	4,124 Added 6.23%	62,050 Common Stock
Feb 13 2023	SELL Open market or private sale	$866,175 $346.47 p/Share	2,500 Reduced 4.14%	57,926 Common Stock
Feb 10 2023	SELL Open market or private sale	$856,900 $342.76 p/Share	2,500 Reduced 3.97%	60,426 Common Stock
Feb 10 2023	BUY Grant, award, or other acquisition	$2,954,917 $345.12 p/Share	8,562 Added 11.98%	62,926 Common Stock
Feb 01 2023	SELL Payment of exercise price or tax liability	$1,119,175 $344.15 p/Share	3,252 Reduced 5.64%	54,364 Common Stock
Feb 01 2023	BUY Exercise of conversion of derivative security	-	7,264 Added 11.2%	57,616 Common Stock
Feb 09 2022	BUY Grant, award, or other acquisition	$2,760,628 $243.27 p/Share	11,348 Added 18.39%	50,352 Common Stock
Feb 01 2022	SELL Payment of exercise price or tax liability	$1,031,620 $245.39 p/Share	4,204 Reduced 9.73%	39,004 Common Stock
Feb 01 2022	BUY Exercise of conversion of derivative security	-	9,368 Added 17.82%	43,208 Common Stock
Feb 08 2021	BUY Grant, award, or other acquisition	$970,823 $205.77 p/Share	4,718 Added 12.24%	33,840 Common Stock
Feb 11 2020	BUY Grant, award, or other acquisition	$1,021,146 $144.25 p/Share	7,079 Added 19.55%	29,122 Common Stock
Oct 25 2019	BUY Open market or private purchase	$108,840 $108.84 p/Share	1,000 Added 4.34%	22,043 Common Stock
Feb 04 2019	BUY Grant, award, or other acquisition	$870,752 $120.17 p/Share	7,246 Added 25.61%	21,043 Common Stock
Dec 02 2018	SELL Payment of exercise price or tax liability	$392,224 $118.64 p/Share	3,306 Reduced 19.33%	13,797 Common Stock
Dec 02 2018	BUY Exercise of conversion of derivative security	-	7,500 Added 30.48%	17,103 Common Stock

AEW

Anne E. White

EVP & Pres, Lilly Neuroscience

Indianapolis, IN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LLY shares.

Notify only if

Value

Insider Trading

Get notified when an Eli Lilly & CO insider buys or sells LLY shares.

Notify only if

Operation

Value

Type

News

Receive news related to ELI LILLY & Co

Track Activities on LLY

Account